Publications & Works

Articles 215
All (215)
SCI-E, SSCI, AHCI (176)
SCI-E, SSCI, AHCI, ESCI (200)
ESCI (23)
Scopus (203)
TRDizin (50)
Other Publications (4)
Papers Presented at Peer-Reviewed Scientific Conferences 195

1. MEDICATION ADHERENCE IN MULTIPLE SCLEROSIS: IMPACT OF DISEASE SUBTYPE AND TREATMENT LINE IN A TERTIARY CARE SETTING

ESCP symposium on clinical pharmacy. From interprofessional education to interprofessional practice, Grenoble, France, 26 - 28 November 2025, pp.98, (Summary Text)

2.

61. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 17 December 2025, pp.138, (Summary Text)

4. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.1045, (Summary Text)

5. Distribution of Cerebral Lesions in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.784, (Summary Text)

6. EDSS Progression and Upper Extremity Disability Worsening in Multiple Sclerosis: Nine-Hole Peg Test Dynamics Across EDSS Strata

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.210-211, (Summary Text)

7. Real-World Effectiveness and Safety of Eculizumab in AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Observational Study

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.729-730, (Summary Text)

8. Comparing the Effectiveness of Supervised vs Web-Based Exercise Programs in People with Severe Multiple Sclerosis

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.1302-1303, (Summary Text)

9.

12. Nöroimmünoloji Okulu, Girne, Cyprus (Kktc), 8 - 11 May 2025, pp.27, (Summary Text)

10. Clinical and Radiological Features of Anti-MOG Associated Cerebral Cortical Encephalitis

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

11. Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

12. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

13.

60. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 02 December 2024, pp.280, (Summary Text)

14. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Denmark, 18 September 2024, vol.30, pp.4-124, (Summary Text)

15. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, pp.107, (Summary Text)

16. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.885, (Summary Text)

20. The Effect of Multiple Sclerosis Sera on Pericyte Survival

9th Joint ECTRIMS-ACTRIMS meeting, Milan, Italy, 11 - 13 October 2023, pp.825-826, (Summary Text)

22. Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome (S31.009)

75th American Academy of Neurology Annual Meeting, BOSTON, United States Of America, 22 - 27 April 2023, vol.100, (Summary Text)

27. B cell gene expression profile in different demyelinating diseases

International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, (Summary Text)

28. Paraplegia following lumbar puncture: a rare complication of spinal dural arteriovenous fistula

2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, (Summary Text)

29. Cladribine treatment in turkish MS patients

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, pp.889-890, (Summary Text)

30. Developing a web-based tele-neurorehabilitation system and implementation in multiple sclerosis patients

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, pp.919-920

31. Validity of the Turkish Version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis

11th Quadrennial Congress of the European-Association-of-Neuroscience-Nursing (EANN), Manchester, England, 19 - 22 March 2022, (Summary Text)

33. Multipl Skleroz Hastalarında Dimetil Fumarat: Bir Gerçek Yaşam Çalışması

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

36. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021, (Unpublished)

40. A14696G HOMOPLASMIC MUTATION IN THE MITOCHONDRIAL tRNAGlu GENE - CASE REPORT

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 May 2020, pp.962, (Summary Text)

42. Analysis of Lesion Localization Pattern of Patients with Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

43. Cortical Laminar Necrosis Following the Rapid Correction of Hyponatremia-A Case Report

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

44. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

46. Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

47. Parenkimal NöroBehçet Hastalığında Lezyon Dağılım Paterninin Olasılık Haritalaması Kullanarak Analizi

55. Ulusal Nöroloji Kongresi 15 Kasım – 21 Kasım 2019, Antalya, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

48. Doz Azaltarak Kesme Stratejisi Fingolimod Sonrası Rebound Aktivitesini Engeller mi?

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

49. İstanbul Tıp Fakültesi’nin Alemtuzumab Gerçek Yaşam Verisi

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 November - 21 September 2019, (Summary Text)

50. The Survival of Turkish Patients with Multiple Sclerosis

35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.3-130, (Summary Text)

51. The survival of patients with multiple sclerosis in Turkey

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, pp.47, (Summary Text)

52. Efficacy of transcutaneous posterior tibial nerve stimulation and pelvic floor muscle training in female MS patients with overactive bladder

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, pp.345, (Summary Text)

54. Submission Group: Describing and understanding functioning; Submitter: Yonca Zenginler Yazgan The effect of fatigue on balance, functionality and body composition in multiple sclerosis

Annual Conference of Rehabilitation in Multiple Sclerosis (RIMS) - Crossing the Interface to Explore New Possibilities, Ljubljana, Slovenia, 20 - 22 June 2019, vol.25, pp.1069-1070, (Summary Text)

55. Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

56. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis (P4.2-048)

71st Annual Meeting of the American-Academy-of-Neurology, Philadelphia, United States Of America, 4 - 10 May 2019, (Summary Text)

57. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

59. Teriflunomid Tedavisinin Multipl Skleroz ile İlişkili Üveit Üzerine Etkisi

Nöro-oftalmoloji – Nöro-otoloji sempozyumu 2019, İstanbul, Turkey, 22 - 24 March 2019, (Summary Text)

64. Nöro-behçet Hastalığı Ne Kadar Süre Tedavi Edilmeli?

54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

67. RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the 'RELOMS-T'

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.174, (Summary Text)

68. Predictors for conversion of radiologically isolated syndrome to multiple sclerosis

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.760-761, (Summary Text)

69. Is placebo effect getting bigger in randomized controlled trials of multiple sclerosis?

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.971-972, (Summary Text)

72. Long-term follow-up of patients with Neuro-Behcet's disease

4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portugal, 16 - 19 June 2018, pp.355, (Summary Text)

73. Body Composition, Muscle Strength and Physical Activity Level in Multiple Sclerosis and Healthy Population: A pilot study

23rd Annual Conference of Rehabilitation in Multiple Sclerosis (RIMS), Amsterdam, Netherlands, 31 May - 02 June 2018, vol.24, pp.879, (Summary Text)

74. A Patient with 4H Syndrome Who Presents in Adulthood

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

84. Neuro-behcet's disease: Analysis of 430 patients

23rd World Congress of Neurology (WCN), Kyoto, Japan, 16 - 21 September 2017, pp.121-122, (Summary Text)

85. Comorbid autoimmunity is not a prognostic factor in multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.486, (Summary Text)

86. HoxB3, a novel biomarker that predicts conversion to multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.428-429, (Summary Text)

87. Vascular inflammation markers in multiple sclerosis: possible role in oligoclonal band formation

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.782-783, (Summary Text)

88. Genetic polymorphism of aquaporin-4 gene in neuromyelitis optica spectrum disorder

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.692-693, (Summary Text)

90. Pseudotumor Cerebri Related to Behçet's disease

3rd Congress of the European Academy of Neurology, Amsterdam, Netherlands, 24 - 27 June 2017, (Summary Text)

91. Pseudotumor cerebri related to Behcet's disease

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, pp.283, (Summary Text)

92. Comparison of the Effects of Two Different Balance Systems on the Balance, Functionality and Fatigue of Multiple Sclerosis Patients

22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation, Barcelona, Spain, 4 - 06 May 2017, vol.23, pp.895, (Summary Text)

93. Evaluation of Oropharyngeal Dysphagia in Patients With Multiple Sclerosis

22nd Annual RIMS Conference on Shaping the Future of MS Rehabilitation, Barcelona, Spain, 4 - 06 May 2017, vol.23, pp.906-907, (Summary Text)

96. Nöromiyelitis Optika Hastalarında Aquaporin-4 Gen Polimorfizmi

52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016, (Full Text)

99. Multipl Skleroz Hastalarının Doğum Ayı İle Cinsiyet Arasında Bir İlişki Var mı?

52. Ulusal Nöroloji Kongresi, Tartışmalı E-poster - 121, Turkey, 25 November - 01 December 2016, (Summary Text)

100. Multiple sclerosis patients perceive their illness different than neurologists

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.428, (Summary Text)

101. Worsening of trigeminal neuralgia by dalfampridine in patients with multiple sclerosis

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.814-815, (Summary Text)

102. Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.310, (Summary Text)

103. The impact of Nintendo Wii fit games on the balance and functionality of multiple sclerosis patients: a randomized controlled study

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.826, (Summary Text)

105. Comparison of Mitoxantrone versus Cyclophosphamide in Patients with Secondary Progressive Multiple Sclerosis

2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, vol.23, pp.601-879, (Summary Text)

108. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Turkey, 27 - 30 April 2016, vol.4, pp.75, (Full Text)

109. A Proteomics Approach for the Identification of Cerebrospinal Fluid Proteins Associated with Conversion to Multiple Sclerosis

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

110. Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

111. Clinical features of patients with relapsing inflammatory optic neuritis

ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.20-21, (Summary Text)

112. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.18-19, (Summary Text)

113. The effects of fatigue on balance and quality of life in patients with multiple sclerosis

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 7 - 10 October 2015, pp.776, (Summary Text)

114. Serum prolactin levels in multiple sclerosis, neuromyelitis optica and clinically isolated syndrome patients

31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 7 - 10 October 2015, pp.716, (Summary Text)

120. Uveitis as a prognostic factor in multiple sclerosis

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013

131. Drop out Rate Of Glatiramer Acetate Is Influenced By Body Mass Index In Multiple Sclerosis Patients

7th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), 06 November 2014

132. Antibodies to DNA repair proteins in HaNDL patients

12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.59, (Summary Text)

134. Comparison of dropout rates of disease modifying therapies in multiple sclerosis

Joint ACTRIMS-ECTRIMS Meeting, Massachusetts, United States Of America, 10 - 13 September 2014, pp.198, (Summary Text)

136. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.942-943, (Summary Text)

137. Cerebral white matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.948-949, (Summary Text)

138. Fingolimod in Relapsing Remitting Multiple Sclerosis: Short Term Safety Profile

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.928, (Summary Text)

142. Validity and Reliability of the Turkish Version of Multiple Sclerosis Related Symptom Scale

EFNS Congress (European Federation of Neurological Societies), İstanbul, Turkey, 31 May - 03 June 2014, vol.678, (Summary Text)

143. VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE MULTIPLE SCLEROSIS-RELATED SYMPTOM SCALE

EFNS-ENS Joint Congress of Neurology, İstanbul, Turkey, 30 May - 03 June 2014, pp.1, (Full Text)

145. Validity and reliability of the Turkish version of the multiple sclerosis-related symptom scale

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, pp.678, (Summary Text)

146. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, pp.379, (Summary Text)

149. Radiologically Isolated Syndrome in Children Report of 5 Children with Long Term Follow Up

Annual Meeting of American Academy of Neurology (66th), United States Of America, 26 April - 03 May 2014, vol.82

150. Aquaporin 1 in Turkish Neuromyelitis Optica Patients with and without Aquaporin 4 Antibodies

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013

156. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013

157. Reduction of IL9 may be an early response marker for interferon β 1a treatment in multiple sclerosis patients

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2 - 05 October 2013, pp.450, (Summary Text)

158. Autoantibodies to aquaporin-1 in Turkish neuromyelitis optica patients with and without aquaporin-4 antibodies

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2 - 05 October 2013, pp.85-86, (Summary Text)

159. Uveitis as a prognostic factor in multiple sclerosis

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2 - 05 October 2013, pp.352, (Summary Text)

161. Arterial CNS Involvement in Behcet's Disease

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, (Summary Text)

162. Uveitis in patients with multiple sclerosis

11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, pp.34, (Summary Text)

163. Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, United States Of America, 21 - 28 April 2012, vol.78, (Summary Text)

164. White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, United States Of America, 21 - 28 April 2012, vol.78, (Summary Text)

165. THE INFLUENCE OF CYP2C9 POLYMORPHISM ON ANTICOAGULATION WITH WARFARIN IN PATIENTS WITH CEREBROVASCULAR DISEASE

15th Congress of the European-Federation-of-Neurological-Societies (EFNS), Budapest, Hungary, 10 - 13 September 2011, vol.18, pp.93, (Summary Text)

166. Anti-Neuronal and Stress-Induced-Phosphoprotein 1 Antibodies in Neuro-Behcet's Disease

63rd AAN Annual Meeting, Hawaii, United States Of America, 9 - 16 April 2011, vol.76, (Summary Text)

167. Increased anti-neuronal antibody positivity in thyroid antibody positive individuals irrespective of neurological findings

10th Congress of the International-Society-of-Neuroimmunology (ISNI), Sitges, Spain, 26 - 30 October 2010, vol.228, pp.159, (Summary Text)

168. Familial effects on the age of onset, initial symptoms and clinical course of multiple sclerosis

20th Meeting of the European Neurological Society, Berlin, Germany, 19 - 23 June 2010, vol.257, pp.1-246, (Summary Text)

169. Clinical characteristics of paediatric onset neuro-Behcet's disease

20th Meeting of the European-Neurological-Society, Berlin, Germany, 19 - 23 June 2010, vol.257

172. Anti-neuronal antibodies in small-cell lung cancer patients without paraneoplastic disorders

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, pp.155, (Summary Text) Sustainable Development

173. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis: is it auto-immune?

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, vol.255, pp.216-217, (Summary Text)

177. Demographic and clinical statistics of multiple sclerosis and demyelinating diseases in an outpatients clinic, Istanbul Faculty of Medicine

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Czech Republic, 11 - 14 October 2007

178. Clinically unsuspected multiple sclerosis: report of 22 cases and review of the literature

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, Prague, Czech Republic, 11 - 14 October 2007, (Summary Text)

179. Evoked potential studies in parenchymal neuro-Behcet's disease predicting outcome

17th Meeting of the European-Neurological-Society, Rhodes, Greece, 16 - 20 June 2007, pp.195, (Summary Text)

181. Devic's neuromyelitis optica: a prospective study

17th Meeting of the European-Neurological-Society, Rhodes, Greece, 16 - 20 June 2007, pp.36

184. Conversion to definite multiple sclerosis in Turkish patients with clinically isolated syndromes

22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, Spain, 27 - 30 September 2006, vol.12, (Summary Text)

185. Probable NMO IgG in turkish patients with Devic's disease, and multiple sclerosis

22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, Spain, 27 - 30 September 2006, vol.12, (Summary Text)

186. Is a 10-year follow-up enough to predict to subsequent disability rate in multiple sclerosis?

22nd Congress of the European-Committee-for-the-Treatment-and-Resarch-in-Multiple-Sclerosis, Madrid, Spain, 27 - 30 September 2006, vol.12, (Summary Text)

187. Probable NMO IgG in Turkish patients with Devic's disease and MS

8th International Conference of Neuroimmunology, Nagoya, Japan, 15 - 19 October 2006, pp.217-218, (Summary Text)

188. CNS consequences of 5-lipoxygenase inhibition/deficiency

25th CINP Congress, Illinois, United States Of America, 9 - 13 July 2006, vol.9, (Summary Text)

190. Neurosyphilis presenting status epilepticus: Two HIV (-) patients with EEG features

18th World Congress of Neurology, Sydney, Australia, 5 - 11 November 2005, vol.238, (Summary Text) Sustainable Development

192. Malignant lymphoma and chronic inflammatory demyelinating polyneuropathy: a case report

7th International Congress of Mediterranean Society of Myology, Aydın, Turkey, 27 - 30 May 2004, vol.23, no.12, pp.51, (Summary Text)

194. AL-Amiloidoz ve Nöromüsküler Komplikasyonları: Olgu Sunumu

4. Uluslararası Klinik Nörofizyoloji Sempozyumu ve 17. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Antalya, Turkey, 1 - 04 May 2000, pp.116, (Full Text)

195. İnce Lif Nöropatisi: Olgu Sunumu

4. Uluslararası Klinik Nörofizyoloji Sempozyumu ve 17. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Antalya, Turkey, 1 - 04 May 2000, pp.132, (Full Text)
Books 4

1. Gen Çevresel Faktörler Etkileşimi - Epigenetik Faktörler

in: Multipl skleroz ve kadın, Ayşe Nur Yüceyar, Rana Karabudak, Hüsnü Efendi, Editor, Bilmedya Yayınevi, İstanbul, pp.9-16, 2023

2. Primer merkezi sinir sistemi vasküliti

in: Nöroimmünoloji, Canan Yücesan, Aslı Tuncer, Cihat Uzunköprü, Editor, Nobel Tıp Kitabevi, İstanbul, pp.277-292, 2023

4. Preface

in: Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editor, Springer-Verlag , London, 2021
Metrics

Publication

415

Publication (WoS)

294

Publication (Scopus)

203

Citation (WoS)

2835

H-Index (WoS)

29

Citation (Scopus)

2687

H-Index (Scopus)

28

Citation (Scholar)

304

H-Index (Scholar)

10

Citation (TrDizin)

8

H-Index (TrDizin)

1

Citation (Sum Other)

8

Total Citation Count

2851

Project

20

Intellectual Property

1

Thesis Advisory

7

Open Access

26
UN Sustainable Development Goals